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Abstract Aldose 1-epimerase or mutarotase (EC 5.1.3.3) is a
key enzyme of carbohydrate metabolism catalysing the inter-
conversion of the K- and L-anomers of hexose sugars such as
glucose and galactose. We identi¢ed an open reading frame in
the human genome (BC014916) which has high sequence simi-
larity to previously identi¢ed bacterial aldose 1-epimerases. This
sequence was cloned into a bacterial expression vector, and ex-
pressed and puri¢ed from this source. Enzyme assays show that
the protein has aldose 1-epimerase activity and exhibits a pref-
erence for galactose over glucose. Site-directed mutagenesis
con¢rmed the involvement of three residues involved in catalysis
and substrate binding.
. 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Common hexose sugars such as glucose and galactose exist
in two predominant forms in aqueous solution, the K- and L-
pyranose structures [1]. These di¡er in the con¢guration of the
hydroxyl group at carbon-1 of the ring. The two forms are
interconverted readily in aqueous solution until an equilibri-
um mixture is formed [2]. Many enzymes of carbohydrate
metabolism exhibit speci¢city for one anomer or the other.
For example, galactokinase, which phosphorylates galactose
at position 1, uses only K-galactose producing K-galactose-1-
phosphate [3,4]. In contrast, glucose and galactose dehydro-
genases exhibit speci¢city for the L-anomer of their respective
sugars [5,6].
Although the anomers will interconvert in water, the rate of
interconversion in the cytoplasm does not seem to be su⁄cient
to provide the needs of metabolic pathways [7,8]. Indeed, the
conditions prevailing in the cytoplasm may be such that very
little spontaneous interconversion occurs [9]. Aldose 1-epimer-
ases (mutarotases) have been isolated from a number of sour-
ces and catalyse rapid anomeric interconversion [7,10^14]. The
enzyme is required for normal lactose metabolism in Escheri-
chia coli. Strains in which the gene has been deleted grow
much more slowly on media containing either sugar [7]. Re-
cently, the crystal structure of galactose mutarotase from Lac-
tococcus lactis has been solved [15,16]. This, together with
recent enzymological work [17], suggests that the enzyme-cat-
alysed reaction proceeds via an acid^base mechanism.
Although the enzyme has been puri¢ed from human tissues
[12,18], the gene has not been identi¢ed nor has the protein
been sequenced. Here we report the identi¢cation of the hu-
man gene for aldose 1-epimerase, the expression of the coding
sequence in E. coli and the characterisation of the puri¢ed,
recombinant protein.
2. Materials and methods
2.1. Cloning, expression and puri¢cation of human aldose 1-epimerase
A cDNA clone containing the sequence of putative human aldose
1-epimerase was obtained from the I.M.A.G.E. consortium
(I.M.A.G.E. clone number 3502667) [19]. The polymerase chain reac-
tion (PCR) was used to amplify the coding sequence. The primers
were designed to introduce the sequences encoding a hexahistidine
tag and an NcoI restriction enzyme site at the 5P-end and an EcoRI
site at the 3P-end of the coding sequence. The fragment was then
cloned into these restriction sites in the expression vector pET-21d
(Novagen). The DNA sequence of the insert was veri¢ed in order to
ensure no PCR-derived mutations had occurred (University of Man-
chester, Faculty of Medicine DNA Sequencing Service).
The resulting plasmid (pET21-GALM) was transformed into E. coli
HMS174(DE3) cells (Novagen) for expression. One to two litres of
these cells were grown shaking in LB media at 37‡C until A600 nm was
between 0.6 and 1.0. The cultures were then induced with IPTG
(2 mM, ¢nal concentration) and grown for a further 2 h. Cells were
harvested by centrifugation (10 min at 5000Ug), resuspended in ap-
proximately 20 ml of bu¡er A (50 mM HEPES-NaOH (pH 8.0), 150
mM NaCl, 10% (v/v) glycerol) and frozen at 380‡C until required.
The protein was puri¢ed essentially as previously described for hu-
man galactokinase [20]. Brie£y, the cells were disrupted by sonication,
the lysate cleared by centrifugation (20 000Ug for 20 min) and the
supernatant loaded onto a 2 ml ProBond nickel-agarose column (In-
vitrogen). The column was washed extensively in 50 mM HEPES-
NaOH (pH 8.0), 500 mM NaCl, 10% (v/v) glycerol and then in the
same bu¡er supplemented with 30 mM imidazole. Protein was eluted
in bu¡er supplemented with 250 mM imidazole. Fractions containing
protein were dialysed overnight against 50 mM HEPES-NaOH (pH
8.0), 150 mM NaCl, 10% (v/v) glycerol, 1.4 mM L-mercaptoethanol,
2 mM EDTA before being snap frozen in liquid nitrogen and stored
at 380‡C.
2.2. Generation of point mutants
Point mutations in aldose 1-epimerase sequence were generated us-
ing the QuikChange method [21]. DNA sequencing was used to verify
the mutations and that no other changes had occurred in the coding
sequence. Mutant proteins were expressed and puri¢ed using the same
protocol as used for the wild-type enzyme.
2.3. Analytical gel ¢ltration
Analytical gel ¢ltration was carried out using a Pharmacia S200
column equilibrated in 50 mM HEPES-NaOH (pH 8.0), 150 mM
NaCl, 10% (v/v) glycerol, 1.4 mM L-mercaptoethanol. The column
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was calibrated using molecular mass standards (Pharmacia). Fractions
(0.5 ml) were collected and subjected to acetone precipitation (as
described previously [22]) prior to analysis by 10% SDS^PAGE.
2.4. Enzyme assays
The K-pyranose forms of glucose and galactose [23] were obtained
from Sigma-Aldrich. The rate of sugar mutarotation was measured
using an Optical Activity AA-100 polarimeter (Department of Chem-
istry, University of Manchester). All reactions were carried out in 25
mM HEPES-NaOH (pH 8.0), 50 mM NaCl at 20‡C. Plots of optical
rotation against time were ¢tted to single exponential curves,
K= k1Wexp(3k2Wt)+k3 (where K is the observed optical rotation at
time t and k1, k2 and k3 are constants) using non-linear curve ¢tting
[24] as implemented in the program GraphPad Prism (GraphPad
Software, San Diego, CA, USA). The initial rate is the gradient of
this curve at t=0 which is equal to 3k1Wk2. Measurement of the
mutarotation rate in the absence of enzyme (v0) allowed the ¢rst order
rate constant (k) to be calculated from the relationship v0 = k[sugar].
Knowing k permitted the calculation of v0 for each sugar concentra-
tion used in the enzyme assay and this spontaneous rate was sub-
tracted from the overall rate to give the initial, enzyme-catalysed
rate (vi). Initial rates were plotted against sugar concentration and
¢tted to the Michaelis^Menton equation vi/[E]T =kcatW[sugar]/
(Km+[sugar]) where kcat is the turnover number, [E]T is the total
enzyme concentration and Km is the Michaelis constant [25].
The mutant enzymes were assayed by coupling the reaction to that
of either glucose or galactose dehydrogenase (ICN and Sigma, respec-
tively) following the methods of Beebe and Frey [17]. These enzymes
are speci¢c for the L-anomer of their respective sugars and the in-
crease in absorbance at 340 nm was measured in a Multiskan Ascent
plate reader. Reactions were carried out at 27‡C in 10 mM HEPES-
NaOH (pH 8.0), 3 mM NADþ in the presence of three units of the
appropriate sugar dehydrogenase and were initiated by the addition of
freshly dissolved sugar. The total reaction volume was 100 Wl. Plots of
A340 nm were ¢tted to the equation A340 nm = k1W(13exp(k2Wt))+k3 and
initial rates calculated from the product k1Wk2. These rates were cor-
rected by subtraction of the initial rate of mutarotation in the absence
of enzyme.
3. Results
3.1. Identi¢cation, expression and puri¢cation of his-tagged
human aldose 1-epimerase
In order to identify a putative aldose 1-epimerase in the
human proteome, we used the protein sequence of the L. lactis
galactose mutarotase (GalM) in a BLAST search [26] against
all human proteins. The best match (P=7U10340) was un-
known protein BC014916 (accession number NP_620156).
Furthermore, the N-terminal sequence of this protein (ASV-
TRAVFGET) agrees well with that of the hog kidney aldose
1-epimerase (VSVTRSVFGET) which has been determined by
mass spectrometry [27]. Overall, the hog kidney sequence (ac-
cession number BAB18973) shows 89% similarity to
BC014916 at the amino acid level. A sequence alignment be-
tween the putative human aldose 1-epimerase and the L. lactis
galactose mutarotase is shown in Fig. 1. The I.M.A.G.E.
cDNA clone corresponding to this sequence was used to clone
the protein coding sequence into the bacterial expression vec-
tor pET-21d such as to introduce a hexahistidine tag at its N-
terminus. This tag enabled the rapid puri¢cation of the pro-
tein (Fig. 2A) from bacterial cell extracts. Typical yields were
approximately 1 mg per litre of culture.
The galactose mutarotase from E. coli is a monomer [17],
whereas the crystal structure of the L. lactis enzyme suggests
this may be a dimer [15]. Gel ¢ltration was used to determine
the native molecular mass of bacterially expressed human al-
dose 1-epimerase. The protein (11 WM) was applied to a Se-
phadex S200 column and eluted at 14.1 ml corresponding to a
molecular mass of 32 kDa (Fig. 2B). The calculated molecular
mass of protein BC014916 is 38 kDa and thus we conclude
that human aldose 1-epimerase is a monomer in solution.
3.2. Kinetic analysis and substrate speci¢city of human aldose
1-epimerase
Polarimetry was used to observe directly changes in the
optical rotation of sugar solutions in the presence and absence
of aldose 1-epimerase. Addition of the protein to a solution of
galactose or glucose resulted in an increase in the mutarota-
tion rate. These increases of rate showed a saturatable depen-
dence on sugar concentration that could be ¢tted to the Mi-
chaelis^Menton equation (Fig. 3). The kinetic parameters
derived from this experiment (Table 1) are of a similar order
of magnitude to those reported for the E. coli enzyme [17].
Fig. 1. Sequence alignment of human protein BC014916 (Hs) with galactose mutarotase from L. lactis, accession number CAB44215 [33] (Ll).
Three key, conserved, residues are highlighted. The two histidines make hydrogen bonds to the ring oxygen of the sugar in the structure of the
L. lactis enzyme and are potential proton donors in the catalytic mechanism. The glutamate makes a hydrogen bond with the hydroxyl group
attached to carbon-1 and is believed to be the catalytic base [15].
Table 1
Kinetic parameters of human aldose 1-epimerase
Sugar
Galactose Glucose
Km/mM 37V10 54V 11
kcat/s31 12 000V1 400 4 900V 370
(kcat/Km)/l mol31 s31 340 000V56 000 90 000V 12 000
Mutarotation rates were observed directly using polarimetry. Reac-
tions were carried out at 20‡C. Values were determined by non-line-
ar curve ¢tting and are shownV the standard error derived from
this procedure.
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The speci¢city constant, kcat/Km, is higher for galactose sug-
gesting that the enzyme prefers this sugar as a substrate.
3.3. Identi¢cation of key catalytic residues in human aldose
1-epimerase
The crystal structure of L. lactis galactose mutarotase re-
veals a number of residues that contact the sugar [15,16].
These residues are all conserved in human aldose 1-epimerase.
Of these three (His-96, His-170 and Glu-304) have been im-
plicated in catalysis. The equivalent residues (His-107, His-176
and Glu-307, highlighted in Fig. 1) in human aldose 1-epimer-
ase were all mutated to alanine. Although all could be ex-
pressed in E. coli, the amount of H176A following induction
was less than for the wild-type or other mutants (data not
shown). Furthermore the yield following puri¢cation of all
these mutants was reduced 5^10-fold compared to the wild-
type. The low yields and the expected low activity of these
mutants made the polarimetry assay impractical. An alterna-
tive assay procedure was developed which involved coupling
the aldose 1-epimerase reaction to the reaction catalysed by
either galactose dehydrogenase or glucose dehydrogenase
(both of which are speci¢c for the L-anomer). The rate of
reaction could be observed by measuring the increase in ab-
sorbance at 340 nm. This approach was complicated by the
high rates of non-enzymatic mutarotation at sugar concentra-
tions approaching the Km of the enzyme. Therefore, we mea-
sured the rates at a very low level of sugar (approximately 1/
100 of the Km). At such low levels of substrate, the Michaelis^
Menton equation simpli¢es to vi = (kcat/Km)W[E]TW[S] [25].
Therefore, the speci¢city constant for each enzyme could be
estimated (Table 2). That the speci¢city constants estimated
this way and by direct polarimetric measurements are of the
same order of magnitude gives us added con¢dence that this
method is valid. H107A shows reduced activity (¢ve- to eight-
fold) with both substrates. In contrast H176A and E307A
show no, or virtually no, aldose 1-epimerase activity. Since
we were able to detect H176A activity at a level 300-fold
reduced compared to the wild-type with galactose as a sub-
strate, the activity of the E307A mutant must be considerably
less than this.
Fig. 2. Expression, puri¢cation and characterisation of the putative
human aldose 1-epimerase. A: The protein was expressed in E. coli
HMS174(DE3) cells as a hexahistidine fusion. This could be readily
puri¢ed on nickel-agarose resin as shown on this 10% SDS^PAGE
gel. B: Gel ¢ltration analysis shows that the protein is a monomer.
The inset shows a 10% SDS^PAGE gel of fractions across the main
elution peak.
Fig. 3. Kinetic analysis of human aldose 1-epimerase with (A) galac-
tose and (B) glucose as substrates. Rates of sugar mutarotation
were measured directly using a polarimeter and initial rates deter-
mined as described in Section 2. The data were ¢t to the Michaelis^
Menton equation using the non-linear curve ¢tting program Graph-
Pad Prism.
Table 2
Speci¢city constants of the wild-type and mutant aldose 1-epimer-
ases
Speci¢city constant, (kcat/Km)/l mol31 s31
Galactose Glucose
Wild-type 310 000V 31 000 56 000V3 000
H107A 63 000V 1 500 7 200V330
H176A 1 000V 290 ND
E307A ND ND
Mutarotation rates were observed at 27‡C by coupling the reaction
to the appropriate sugar dehydrogenase. Galactose was present at a
concentration of 360 WM and glucose at 670 WM. ND ^ no detect-
able activity. Values were determined by non-linear curve ¢tting and
are shownV the standard error derived from this procedure.
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4. Discussion
Human protein BC014916 has been shown to be an active
aldose 1-epimerase. The enzyme shows a small (approximately
four-fold) preference for galactose over glucose. A key func-
tion of this enzyme is likely to be the maintenance of the
equilibrium between the K- and L-anomers of galactose, thus
ensuring that galactokinase is kept supplied with su⁄cient
quantities of the K-anomer. In light of this we propose that
the gene should be renamed GALM (galactose mutarotase) in
order to be consistent with the other genes encoding enzymes
of the Leloir pathway (GALK1, GALT and GALE).
The crystal structure of L. lactis galactose mutarotase
[15,16] and enzymological studies of the E. coli enzyme [17]
suggest that the reaction proceeds via an acid^base mecha-
nism. The crystal structure implicates two histidine residues
and one glutamate. The proposed mechanism involves the si-
multaneous protonation of the ring oxygen of the sugar by
one of the histidines and the abstraction of a proton from the
hydroxyl attached to carbon-1 leading to ring opening. Re-
versal of these protonation events results in ring closure and
reversal of the con¢guration about carbon-1. Mutation of the
equivalent residues in human aldose 1-epimerase severely re-
duced the activity of the enzyme. Furthermore, the yields of
all three mutants (especially H176A) from over-producing
bacteria were reduced suggesting that they are structurally
less stable than the wild-type. The E307A mutant has virtually
no activity, consistent with the role of this residue as a cata-
lytic base. The results from the histidine mutants are more
ambiguous. Our results are similar to those obtained with
the E. coli enzyme. In this system mutation of the equivalent
residue to H107 resulted in reduced, but not zero, activity
whereas mutation of the equivalent residue to H176 resulted
in no measurable activity [17]. Based on this, it has been
postulated that this second histidine residue is the main pro-
ton donor [15]. Our results suggest that the mechanism of
human aldose 1-epimerase is similar to that of bacterial mu-
tarotases.
The other enzymes of the human Leloir pathway ^ galacto-
kinase (GALK1), galactose-1-phosphate uridyl transferase
(GALT) and UDP-galactose 4-epimerase (GALE) ^ are all
known [28^30]. Furthermore, mutations in all these genes
can give rise to the hereditary disease galactosemia [31,32].
The main symptom of this disease is early onset cataracts
although mental retardation, kidney and liver damage are
also known. Now that the gene for the fourth enzyme of
the pathway, GALM, has been identi¢ed, it will be interesting
to see if any disease-causing mutations map to this locus.
Identi¢cation of the gene encoding human aldose 1-epimer-
ase will permit other studies on the structure and function of
this enzyme. Although the maintenance of the anomeric equi-
librium of galactose is likely to be a major function, the en-
zyme may also play a role in the metabolism of glucose and
other sugars. Early work on this enzyme hypothesised that it
may play a role in the transport of glucose into cells [13].
Knowledge of the gene and protein sequence will permit the
tissue expression pattern and sub-cellular location of the en-
zyme to be determined. Such information will help us start to
elucidate the range of metabolic functions performed by hu-
man aldose 1-epimerase.
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